Ocular Discomfort Assessment After Intravitreal Injections

• Status: Completed
• Trial end date: 2017-07-01
• Target enrollment: 0
• Participant gender: All

Summary

In this study, ocular discomfort following intravitreal injection in naïve patients will be studied, as well as the efficacy of wetting agent (Optive eyewash) to prevent ocular discomfort.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre Hospitalier Intercommunal Creteil

Criteria

Inclusion Criteria:

• Patient over 18 years old

• Patient with social healthcare

• Patient understanding French language

• Patient requiring anti-VEGF treatment by intravitreal injection

Exclusion Criteria:

• Patient treated by Ozurdex® before

• Patient with known and treated ocular dryness

• Non naive patient for intravitreal injection

• Hypersensitivity to Carmellose

• Patient who received wetting agent within the 3 last months

• History of povidone-iodine allergy

• Pregnant or breastfeeding mother